The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Reported Adherence as a Determinant of Response to Highly Active Antiretroviral Therapy in Children Who Have Human Immunodeficiency Virus Infection
Abstract
Objective. The complexity of highly active antiretroviral therapy (HAART), with multiple medications, formulations, and dosing intervals, makes adherence challenging. Little is known about the adherence of children to HAART. The objective of this study was to identify correlates of adherence to HAART and the relationship between adherence and study outcomes in a pediatric clinical trial. Methods. Pediatric AIDS Clinical Trials Group 377 is a phase I/II randomized trial of 4 HAART regimens in antiretroviral-experienced, clinically stable children aged 4 months to 17 years. The 4 treatment arms include various 3- or 4-drug combinations of d4T, 3TC, nevirapine, ritonavir, and nelfinavir. After informed consent was obtained, 193 children were enrolled between December 1997 and September 1998. Questionnaires were developed to collect subject- or caregiver-reported adherence to study medications and to identify problems associated with medication administration. Every 3 months, the number of doses of each medication missed during the 3 days preceding the study visit was recorded. Full adherence (FA) and non-full adherence were defined as missing no doses and missing at least 1 dose, respectively. Results. Adherence data from study week 48 or the most recent study visit were available for 125 children (week 48 for 109 children). Overall, 70% of children reported FA and 30% reported non-full adherence. Adherence did not differ by treatment arm, age, or the child’s knowledge of his or her human immunodeficiency virus infection status. There was a suggestion that adherence was less for white than nonwhite children (40% vs 73% FA) and did not differ between black and Hispanic children. Rates of FA were 82% for d4T, 79% for 3TC, 83% for nevirapine, 84% for ritonavir, and 68% for nelfinavir. Despite the similar rates of FA, difficulties with taking specific medications were reported most frequently for ritonavir and nelfinavir. These included poor taste, patient refusal, and scheduling problems. Adherence was associated with the virologic response: FA was seen in 92% of children with ≥2 log10 drop in viral load and in 64% with <2 log10 drop in viral load. Conclusion. In children, reported adherence predicts the virologic response to HAART therapy and is a useful measure of adherence. Interventions and regimens to increase adherence to HAART should result in an improved outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Clinical Trials: A Practical Approach.
Hill, I. D., & Pocock, S. J. (1984) · Biometrics · doi:10.2307/2531186 · Cited by 2,930
Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., Bamberger, J. D., Chesney, M. A., & Moss, A. (2000) · AIDS · doi:10.1097/00002030-200003100-00008 · Cited by 1,033
A Comparison Study of Multiple Measures of Adherence to HIV Protease Inhibitors
Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., Christian, J., Maldonado, T., Duran, D., Kaplan, A. H., et al. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-10-200105150-00011 · Cited by 758
Factors Affecting Adherence to Antiretroviral Therapy
Chesney, M. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313849 · Cited by 702
Mulder, J., McKinney, N., Christopherson, C., Sninsky, J., Greenfield, L., & Kwok, S. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.2.292-300.1994 · Cited by 558
Haubrich, R. H., Little, S. J., Currier, J. S., Forthal, D. N., Kemper, C. A., Beall, G. N., Johnson, D., Dubé, M. P., Hwanga, J. Y., & McCutchan, J. A. (1999) · AIDS · doi:10.1097/00002030-199906180-00014 · Cited by 531
Descamps, D. (2000) · JAMA · doi:10.1001/jama.283.2.205 · Cited by 367
Hogg, R. S., Yip, B., Kully, C., Craib, K. J. P., O’Shaughnessy, M. V., Schechter, M. T., & Montaner, J. S. G. (1999) · Europe PMC (PubMed Central) · Cited by 316
WATSON, D. C., & FARLEY, J. J. (1999) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199908000-00006 · Cited by 201
Cited by
Interventions for enhancing medication adherence
Nieuwlaat, R., Wilczynski, N., Navarro, T., Hobson, N., Jeffery, R., Keepanasseril, A., Agoritsas, T., Mistry, N., Iorio, A., Jack, S., et al. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub4 · Cited by 2,945
Interventions for enhancing medication adherence
Haynes, R. B., Ackloo, E., Sahota, N., McDonald, H. P., & Yao, X. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub3 · Cited by 1,244
Interventions for enhancing medication adherence
Haynes, R., Yao, X., Degani, A., Kripalani, S., Garg, A., & McDonald, H. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000011.pub2 · Cited by 517
Adherence to treatment in adolescents
Taddeo, D., Egedy, M., & Frappier, J.-Y. (2008) · Paediatrics & Child Health · doi:10.1093/pch/13.1.19 · Cited by 377
Evidence-based Assessment of Adherence to Medical Treatments in Pediatric Psychology
Quittner, A. L., Modi, A. C., Lemanek, K. L., Ievers-Landis, C. E., & Rapoff, M. A. (2008) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsm064 · Cited by 329
Predictors of Adherence to Antiretroviral Medications in Children and Adolescents With HIV Infection
Williams, P. L., Storm, D., Montepiedra, G., Nichols, S., Kammerer, B., Sirois, P. A., Farley, J., Malee, K., & for the PACTG 219C Team (2006) · Pediatrics · doi:10.1542/peds.2006-0493 · Cited by 283
Brady, M. T., Oleske, J. M., Williams, P. L., Elgie, C., Mofenson, L. M., Dankner, W. M., & Van Dyke, R. B. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b9869f · Cited by 278
Self-citationYouths and HIV/AIDS: Psychiatry's Role in a Changing Epidemic
Donenberg, G. R., & Pao, M. (2005) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000166381.68392.02 · Cited by 258
Metadata
- Authors
- Van Dyke, R. B., Lee, S., Johnson, G. M., Wiznia, A., Mohan, K., Stanley, K., Morse, E. V., Krogstad, P. A., Nachman, S., Pediatric AIDS Clinical Trials Group Adherence Subcommittee, & Pediatric AIDS Clinical Trials Group 377 Study Team
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2002-04-01
- Volume
- 109
- Issue
- 4
- Pages
- e61-e61
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2119218670
- Cited by
- 291
- References
- 14
- FWCI
- 12.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.